186 related articles for article (PubMed ID: 38066893)
1. How old is too old? Frailty and geriatric assessments of older patients undergoing allogeneic HCT.
Jayani RV
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):709-714. PubMed ID: 38066893
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.
Wildes TM; Stirewalt DL; Medeiros B; Hurria A
J Natl Compr Canc Netw; 2014 Jan; 12(1):128-36. PubMed ID: 24453296
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns.
Al-Mansour Z; Ramanathan M; Cerny J
Drugs Aging; 2018 Dec; 35(12):1055-1064. PubMed ID: 30302674
[TBL] [Abstract][Full Text] [Related]
4. Use of geriatric assessment in hematopoietic cell transplant.
Jayani R; Rosko A; Olin R; Artz A
J Geriatr Oncol; 2020 Mar; 11(2):225-236. PubMed ID: 31761694
[TBL] [Abstract][Full Text] [Related]
5. Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies.
Lin RJ; Elko TA; Devlin SM; Shahrokni A; Jakubowski AA; Dahi PB; Perales MA; Tamari R; Shaffer BC; Sauter CS; Papadopoulos EB; Gyurkocza B; Korc-Grodzicki B; Barker JN; Maloy MA; Giralt SA
Bone Marrow Transplant; 2020 Jan; 55(1):157-164. PubMed ID: 31471572
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.
Muffly LS; Boulukos M; Swanson K; Kocherginsky M; Cerro PD; Schroeder L; Pape L; Extermann M; Van Besien K; Artz AS
Biol Blood Marrow Transplant; 2013 Mar; 19(3):429-34. PubMed ID: 23160006
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a randomised controlled trial on impact of comprehensive geriatric and supportive assessment versus standard care in older adults with cancer undergoing curative treatment: The Geriatric Oncology SuPportive clinic for ELderly (GOSPEL) study.
Goh WY; Neo HY; Teo HL; Koh MYH; Griva K; Lim MY; Ho FCH; Hum AYM
J Geriatr Oncol; 2023 Jan; 14(1):101342. PubMed ID: 35843845
[TBL] [Abstract][Full Text] [Related]
8. Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot study.
Ombres R; des Bordes JKA; Popat UR; Yennu S; Champlin RE; Mohile SG; Kebriaei P; Holmes HM
J Geriatr Oncol; 2022 Mar; 13(2):194-199. PubMed ID: 34493481
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.
Lin RJ; Hilden PD; Elko TA; Dahi PB; Shahrokni A; Jakubowski AA; Perales MA; Sauter CS; Castro-Malaspina HR; Barker JN; Shaffer BC; Tamari R; Papadopoulos EB; Maloy MA; Korc-Grodzicki B; Giralt SA
Blood Adv; 2019 Jan; 3(1):12-20. PubMed ID: 30606722
[TBL] [Abstract][Full Text] [Related]
11. Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.
Lew MV; Ren Y; Lowder YP; Siamakpour-Reihani S; Ramalingam S; Romero KM; Thompson JC; Bohannon LM; McIntyre J; Tang H; Van Opstal J; Johnson E; Cohen HJ; Bartlett DB; Pastva AM; Morey M; Hall KS; Smith P; Peters KB; Somers TJ; Kelleher S; Smith SK; Wischmeyer PE; Lin PH; Wood WA; Thorpe G; Minor K; Wiggins K; Hennig T; Helms T; Welch R; Matthews B; Liu J; Burleson J; Aberant T; Engemann AK; Henshall B; Darby M; Proch C; Dellascio M; Pittman A; Suminguit J; Choi T; Gasparetto C; Long GD; Lopez RD; Sarantopoulos S; Horwitz ME; Chao NJ; Sung AD
Transplant Cell Ther; 2022 Aug; 28(8):498.e1-498.e9. PubMed ID: 35595226
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
Lin RJ; Cohen AG; Stabler SM; Devlin SM; Elko TA; Maloy MA; Korc-Grodzicki B; Alexander K; Kramer D; Sanchez-Escamilla M; Castillo Flores N; Barker JN; Cho C; Dahi PB; Gyurkocza B; Papadopoulos EB; Perales MA; Politikos I; Ponce DM; Sauter CS; Scordo M; Shaffer BC; Shah GL; Tamari R; Young JW; Jakubowski AA; Giralt SA; Nelson JE
J Palliat Med; 2020 Dec; 23(12):1653-1657. PubMed ID: 32216649
[No Abstract] [Full Text] [Related]
13. Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail Recipients.
Pamukcuoglu M; Bhatia S; Weisdorf DJ; DeFor TE; Ustun C; Nayar M; Holtan SG; Jurdi NE; Thyagarajan B; Brunstein CG; Bachanova V; Warlick ED; Severseike B; Te HS; Lund T; Arora M
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2454-2460. PubMed ID: 31394273
[TBL] [Abstract][Full Text] [Related]
14. Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.
Derman BA; Kordas K; Ridgeway J; Chow S; Dale W; Lee SM; Aguada E; Jakubowiak AJ; Jasielec J; Kline J; Kosuri S; Larson RA; Liu H; Mortel M; Odenike O; Pisano J; Riedell P; Stock W; Bishop MR; Artz AS
Blood Adv; 2019 Nov; 3(22):3488-3498. PubMed ID: 31725894
[TBL] [Abstract][Full Text] [Related]
15. The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients.
Wall SA; Olin R; Bhatt V; Chhabra S; Munshi P; Hacker E; Hashmi S; Hassel H; Howard D; Jayani R; Lin R; McCurdy S; Mishra A; Murthy H; Popat U; Wood W; Rosko AE; Artz A
Transplant Cell Ther; 2023 Oct; 29(10):632.e1-632.e10. PubMed ID: 37137442
[TBL] [Abstract][Full Text] [Related]
16. [GERIATRIC ONCOLOGY - CANCER TREATMENT IN OLDER ADULTS AND OLDEST-OLD].
Leibowitz R; Plotnikov G; Yarom N; Merose R
Harefuah; 2022 Jan; 161(1):21-25. PubMed ID: 35077055
[TBL] [Abstract][Full Text] [Related]
17. Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Mishra A; Preussler JM; Bhatt VR; Bredeson C; Chhabra S; D'Souza A; Dahi PB; Hacker ED; Gowda L; Hashmi SK; Howard DS; Jakubowski A; Jayani R; Koll T; Lin RJ; Olin RL; Popat UR; Rodriguez C; Rosko A; Sabloff M; Sorror ML; Sung AD; Ustun C; Wood WA; Burns L; Artz A
Transplant Cell Ther; 2021 Jul; 27(7):617.e1-617.e7. PubMed ID: 33836312
[TBL] [Abstract][Full Text] [Related]
18. Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.
Elsawy M; Sorror ML
Bone Marrow Transplant; 2016 Oct; 51(10):1283-1300. PubMed ID: 27272454
[TBL] [Abstract][Full Text] [Related]
19. Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation.
Maffini E; Festuccia M; Ursi M; Barbato F; Dicataldo M; Roberto M; Campanini E; Dan E; De Felice F; De Matteis S; Storci G; Bonafè M; Arpinati M; Bonifazi F
Curr Opin Hematol; 2023 Jan; 30(1):14-21. PubMed ID: 36539361
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.
Zhu J; Campagne O; Torrice CD; Flynn G; Miller JA; Patel T; Suzuki O; Ptachcinski JR; Armistead PM; Wiltshire T; Mager DE; Weiner DL; Crona DJ
Clin Transl Sci; 2021 May; 14(3):908-918. PubMed ID: 33502111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
